Emerging links between E2F control and mitochondrial function

Cancer Research

Volumn 75, Issue 4, 2015, Pages 619-623

  Benevolenskaya, Elizaveta V ^a   Frolov, Maxim V ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D; CYCLIN DEPENDENT KINASE 4; GA BINDING PROTEIN; JANUS KINASE; MYC PROTEIN; PALBOCICLIB; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; WNT PROTEIN; PROTEIN P53;

AEROBIC METABOLISM; APOPTOSIS; BIOGENESIS; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CELL VIABILITY; COMPLEX FORMATION; DNA DAMAGE; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; ENERGY YIELD; GENETIC CONSERVATION; MANTLE CELL LYMPHOMA; MITOCHONDRION; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL SURVIVAL; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOCHONDRIA; NEOPLASMS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84923188503     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-2173     Document Type: Review

References (36)

1. Blais A, Dynlacht BD. Hitting their targets: an emerging picture of E2F and cell cycle control. Curr Opin Genet Dev 2004;14:527-32.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
3. Polager S, Ginsberg D. p53 and E2f: partners in life and death. Nat Rev Cancer 2009;9:738-48.
4. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 2002;16:245-56.
5. van den Heuvel S, Dyson NJ. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 2008;9:713-24.
6. Yeo HC, Beh TT, Quek JJL, Koh G, Chan KKK, Lee D-Y. Integrated transcriptome and binding sites analysis implicates E2F in the regulation of self-renewal in human pluripotent stem cells. Selvarajoo K, editor. PLoS ONE 2011;6:e27231.
7. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R, et al. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 2004;16:399-411.
8. Scarpulla RC. Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann N Y Acad Sci 2008;1147:321-34.
9. Dejosez M, Levine SS, Frampton GM, Whyte WA, Stratton SA, Barton MC, et al. Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells. Genes Dev 2010;24:1479-84.
10. Moon N-S, Di Stefano L, Morris EJ, Patel R, White K, Dyson NJ. E2F and p53 induce apoptosis independently during Drosophila development but intersect in the context of DNA damage. PLoS Genet 2008;4: e1000153.
11. Ambrus AM, Islam ABMMK, Holmes KB, Moon N-S, Lopez-Bigas N, Benevolenskaya EV, et al. Loss of dE2F compromises mitochondrial function. Dev Cell 2013;27:438-51.
12. Abdelwahid E, Yokokura T, Krieser RJ, Balasundaram S, Fowle WH, White K. Mitochondrial disruption in Drosophila apoptosis. Dev Cell 2007;12: 793-806.
13. Goyal G, Fell B, Sarin A, Youle RJ, Sriram V. Role of mitochondrial remodeling in programmed cell death in Drosophila melanogaster. Dev Cell 2007;12:807-16.
14. Goto Y, Hayashi R, Kang D, Yoshida K. Acute loss of transcription factor E2F1 induces mitochondrial biogenesis in Hela cells. J Cell Physiol 2006;209:923-34.
15. Hsieh MCF, Das D, Sambandam N, Zhang MQ, Nahle Z. Regulation of the PDK4 Isozyme by the Rb-E2F1 Complex. J Biol Chem 2008;283:27410-7.
16. Fajas L, Annicotte J-S, Miard S, Sarruf D, Watanabe M, Auwerx J. Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1 (-/-)mice. J Clin Invest 2004;113:1288-95.
17. Sankaran VG, Orkin SH, Walkley CR. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev 2008;22:463-75.
18. Annicotte J-S, Blanchet E, Chavey C, Iankova I, Costes S, Assou S, et al. The CDK4-pRB-E2F1 pathway controls insulin secretion. Nat Cell Biol 2009;11:1017-23.
19. Asp P, Acosta-Alvear D, Tsikitis M, van Oevelen C, Dynlacht BD. E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation. Genes Dev 2009;23:37-53.
20. Blanchet E, Annicotte J-S, Pradelli LA, Hugon G, Matecki S,Mornet D, et al. E2F transcription factor-1 deficiency reduces pathophysiology in the mouse model of Duchenne muscular dystrophy through increased muscle oxidative metabolism. Hum Mol Genet 2012;21:3910-7.
21. Blanchet E, Annicotte J-S, Lagarrigue S, Aguilar V, Clapé C, Chavey C, et al. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol 2011;13:1146-52.
22. Chong J-L, Wenzel PL, Sáenz-Robles MT, Nair V, Ferrey A, Hagan JP, et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 2009;462:930-4.
23. Folch J, Junyent F, Verdaguer E, Auladell C, Pizarro JG, Beas-Zarate C, et al. Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death. Neurotox Res. Springer-Verlag; 2012;22:195-207.
24. Raimundo N, Song L, Shutt TE, McKay SE, Cotney J, Guan M-X, et al. Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness. Cell 2012;148:716-26.
25. Gemin A, Sweet S, Preston TJ, Singh G. Regulation of the cell cycle in response to inhibition of mitochondrial generated energy. Biochem Biophys Res Commun 2005;332:1122-32.
26. Macleod KF. The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system. Nat Rev Cancer 2008;8: 769-81.
27. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG. Binding of pRB to thePHDprotein RBP2 promotes cellular differentiation. Mol Cell 2005;18:623-35.
28. Lopez-Bigas N, Kisiel TA, DeWaal DC, Holmes KB, Volkert TL, Gupta S, et al. Genome-wide analysis of theH3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol Cell 2008;31: 520-30.
29. Ciavarra G, Zacksenhaus E. Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift. J Cell Biol 2010;191:291-301.
30. Ianari A, Natale T, Calo E, Ferretti E, Alesse E, Screpanti I, et al. Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell 2009;15:184-94.
31. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, et al. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 1998;12:95-106.
32. Vo T-T, Ryan J, Carrasco R, Neuberg D, Rossi DJ, Stone RM, et al. Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML. Cell. Elsevier Inc 2012;151:344-55.
33. Toogood PL, Harvey PJ, Repine JT, Sheehan DJ, VanderWel SN, Zhou H, et al. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. J Med Chem 2005;48:2388-406.
34. Leonard JP, LaCasce AS, Smith MR, Noy A, Chirieac LR, Rodig SJ, et al. Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood 2012;119:4597-607.
35. Alinari L, Prince CJ, Edwards RB, Towns WH, Mani R, Lehman A, et al. Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol. Clin Cancer Res 2012;18:4600-11.
36. Dean JL, McClendon AK, Knudsen ES. Modification of the DNA damage response by therapeutic CDK4/6 inhibition. J Biol Chem 2012;287: 29075-87.